ICGex

Tourneau, C.L et al.
Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial
Lancet Oncol.
doi: 10.1016/S1470-2045(15)00188-6

ICGex

Siudeja K. et al.
Frequent Somatic Mutation in Adult Intestinal StemCells Drives Neoplasia and Genetic Mosaicism during Aging
Cell Stem Cell.
doi: 10.1016/j.stem.2015.09.016

ICGex

Holmes A. et al.
Mechanistic signatures of HPV insertions in cervical carcinomas
Npj Genomic Medicine. 2015
doi:

ICGex

Lebofsky R. et al.
Circulating tumor DNA as a non-invasive substitute to metastasis biopsy for tumor genotyping and personalized medicine in a prospective trial across all tumor types
Molecular Oncology. 2015
doi:

ICGex

Madic J. et al.
Circulating tumor DNA and circulating tumor cells in metastatic triple negative breast cancer patients
Int. J. Cancer. 2015
doi:

ICGex

Grünewald, T.G.P. et al.
Chimeric EWSR1-FLI1 regulates the Ewing sarcoma susceptibility gene EGR2 via a GGAA microsatellite
Nature Genetics. 2015
doi:

ICGex

Bellini A. et al.
Deep sequencing reveals occurrence of sub-clonal ALK mutations in neuroblastoma at diagnosis
Clin. Cancer Res. 2015
doi:

ICGex

Smith M.J. et al.
Mutations in LZTR1 add to the complex heterogeneity of schwannomatosis
Neurology. 2015
doi:

ICGex

Manfrini N. et al.
RNA-processing proteins regulate Mec1/ATR activation by promoting generation of RPA-coated ssDNA
EMBO Rep. 2015
doi:

ICGex

Grünewald TGP. et al.
Chimeric EWSR1-FLI1 regulates the Ewing sarcoma susceptibility gene EGR2 via a GGAA microsatellite.
Nature Genetics (2015)
doi: 10.1038/ng.3363